Section Arrow
Quote
RXRX.NASDAQ
- Recursion Pharmaceuticals
Quotes are at least 15-min delayed:2026/03/28 04:05 EDT
Regular Hours
Last
 2.94
-0.21 (-6.67%)
Day High 
3.12 
Prev. Close
3.15 
1-M High
3.76 
Volume 
19.29M 
Bid
2.95
Ask
2.96
Day Low
2.91 
Open
3.09 
1-M Low
3.08 
Market Cap 
1.64B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.29 
20-SMA 3.4 
50-SMA 3.8 
52-W High 7.18 
52-W Low 2.98 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.44/--
Enterprise Value
1.70B
Balance Sheet
Book Value Per Share
2.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
74.26M
Operating Revenue Per Share
0.10
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITRMIterum Therapeutics plc0.0356-0.1404-79.77%-- 
ARTLArtelo Biosciences Inc10.54+7.35+230.41%-- 
ONCOOnconetix Inc1.94-1.28-39.75%0PE
RCKTRocket Pharmaceuticals3.77-0.92-19.62%-- 
ADMAADMA Biologics9.25+0.96+11.58%13.87PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.